Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors $18.30 -0.06 (-0.33%) Closing price 03/26/2025 04:00 PM EasternExtended Trading$18.30 0.00 (0.00%) As of 03/26/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock TLX vs. TEVA, SMMT, ITCI, GMAB, MRNA, VTRS, RDY, ASND, SRPT, and PCVXShould you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Moderna (MRNA), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Sarepta Therapeutics (SRPT), and Vaxcyte (PCVX). These companies are all part of the "pharmaceutical products" industry. Telix Pharmaceuticals Limited American Depositary Shares vs. Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Moderna Viatris Dr. Reddy's Laboratories Ascendis Pharma A/S Sarepta Therapeutics Vaxcyte Teva Pharmaceutical Industries (NYSE:TEVA) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Do analysts prefer TEVA or TLX? Teva Pharmaceutical Industries presently has a consensus target price of $23.43, indicating a potential upside of 49.46%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus target price of $22.00, indicating a potential upside of 20.22%. Given Teva Pharmaceutical Industries' higher possible upside, research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to TEVA or TLX? In the previous week, Teva Pharmaceutical Industries had 16 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 22 mentions for Teva Pharmaceutical Industries and 6 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Telix Pharmaceuticals Limited American Depositary Shares' average media sentiment score of 0.82 beat Teva Pharmaceutical Industries' score of 0.75 indicating that Telix Pharmaceuticals Limited American Depositary Shares is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 10 Very Positive mention(s) 0 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Telix Pharmaceuticals Limited American Depositary Shares 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in TEVA or TLX? 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has better earnings and valuation, TEVA or TLX? Telix Pharmaceuticals Limited American Depositary Shares has lower revenue, but higher earnings than Teva Pharmaceutical Industries. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.54B1.07-$1.64B-$1.45-10.81Telix Pharmaceuticals Limited American Depositary Shares$783.21M7.87N/AN/AN/A Does the MarketBeat Community favor TEVA or TLX? Teva Pharmaceutical Industries received 1329 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 67.84% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes133367.84% Underperform Votes63232.16% Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes4100.00% Underperform VotesNo Votes Is TEVA or TLX more profitable? Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-9.91% 42.46% 6.65% Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A SummaryTeva Pharmaceutical Industries beats Telix Pharmaceuticals Limited American Depositary Shares on 9 of the 14 factors compared between the two stocks. Remove Ads Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLX vs. The Competition Export to ExcelMetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.16B$6.90B$5.62B$8.13BDividend YieldN/A2.73%4.56%4.00%P/E RatioN/A7.1824.5419.09Price / Sales7.87226.87386.7694.71Price / CashN/A65.6738.1634.64Price / BookN/A6.486.974.36Net IncomeN/A$142.41M$3.20B$247.23M7 Day Performance4.39%-2.89%-2.19%-0.34%1 Month Performance-3.17%-4.52%3.14%-3.60%1 Year PerformanceN/A-8.69%11.39%2.01% Telix Pharmaceuticals Limited American Depositary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$18.30-0.3%$22.00+20.2%N/A$6.16B$783.21M0.00N/AGap UpTEVATeva Pharmaceutical Industries2.5962 of 5 stars$16.74+2.5%$23.43+40.0%+10.8%$18.97B$16.54B-11.5436,800Analyst DowngradeShort Interest ↑SMMTSummit Therapeutics2.6953 of 5 stars$20.13-3.2%$34.11+69.5%+431.8%$14.85B$700,000.00-71.89110Analyst UpgradeNews CoverageGap UpITCIIntra-Cellular Therapies3.6489 of 5 stars$131.45+0.1%$106.08-19.3%+95.6%$13.98B$680.50M-151.09560Positive NewsGMABGenmab A/S4.068 of 5 stars$20.80+1.4%$41.33+98.7%-36.4%$13.76B$21.53B11.952,204Short Interest ↑Gap DownMRNAModerna4.1218 of 5 stars$34.71+0.3%$59.60+71.7%-70.7%$13.39B$3.20B-3.743,900VTRSViatris1.8801 of 5 stars$9.25+1.6%$10.50+13.5%-22.8%$11.04B$14.74B-12.5037,000Short Interest ↑RDYDr. Reddy's Laboratories3.4752 of 5 stars$13.23+4.3%$17.00+28.5%-8.8%$11.04B$311.31B21.0624,800Positive NewsASNDAscendis Pharma A/S2.946 of 5 stars$168.84+10.4%$202.36+19.9%+5.5%$10.25B$363.64M-23.781,017Positive NewsHigh Trading VolumeSRPTSarepta Therapeutics4.8507 of 5 stars$101.35+4.3%$170.41+68.1%-43.2%$9.83B$1.90B81.081,314PCVXVaxcyte2.0514 of 5 stars$75.23+1.2%$147.50+96.1%+1.7%$9.69BN/A-16.35160Positive News Remove Ads Related Companies and Tools Related Companies TEVA Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives MRNA Alternatives VTRS Alternatives RDY Alternatives ASND Alternatives SRPT Alternatives PCVX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLX) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLX Stock Free TLX Stock Alerts